Non-Deal Roadshow

News & Media Contact Access Your Account Careers Corporate Access

Nov 3 2026 Tuesday

BriaCell Therapeutics Corp. (Nasdaq: BCTX)

BriaCell Therapeutics Corp. (Nasdaq: BCTX) (The “Company”)

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells.
For additional information including SEC filings please see: https://briacell.com/

A * denotes a required field

We're sorry, but this form has spam protection that requires JavaScript to be enabled to work correctly. If you'd like to contact us via this form, please enable JavaScript in your browser and reload the page.

First Name*

Last Name*

Fund

Your Rep's Email Address*

Email Address*

Phone Number*

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.